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Cytokines play a major role in the control of inflammatory responses, participate in the regulation of blood phagocyte 
activities and as such are used for immunomodulatory therapy. In the present study, the influence of IL-10 on human 
blood phagocyte activity in the presence/absence of IL-6, IL-8 and TNF-α was tested in vitro. Our research analyzed 
the effects of cytokines on the production of reactive oxygen species measured by chemiluminescence and flow 
cytometry, and on the expression of surface molecules (CD11b, CD15, CD62L, CD31) measured by flow cytometry. 
IL-10 had no inhibitory effect on reactive oxygen species production and the expression of any examined adhesion 
molecule by resting or stimulated blood phagocytes within 3 h of incubation. Conversely, TNF-α, IL-6, and IL-8 
increased reactive oxygen species production and the expression of CD11b and CD15 on both neutrophils and 
monocytes and decreased the expression of CD62L. These priming effects of the tested pro-inflammatory cytokines 
were not affected by IL-10. The obtained results suggest that IL-10 does not directly control blood phagocyte activation. 
These results also provide better information about the contribution of IL-6, IL-8 and TNF-α to the regulation of blood 









Polymorphonuclear leukocytes (PMNL) and 
monocytes are the most important blood phagocytes that 
play a key role in the non-specific immune defense of the 
body. Phagocytosis is accompanied by an oxidative burst, 
a process in which a significant increase in the production 
of reactive oxygen species (ROS) occurs (Drábiková et 
al. 2000). However, an overproduction of ROS evokes 
tissue inflammation and injury (Land et al. 1994, Lojek et 
al. 1998, Huber et al. 2000, Hamar et al. 2003). 
Cytokines may play a critical role in triggering this 
systemic inflammatory response. A sharp increase in the 
plasma concentration of both pro- and anti-inflammatory 
cytokines was observed during inflammatory pathological 
states including septic shock (Huber et al. 2000), organ 
transplantation ( Lang et al. 1996, Wan et al. 1997, 
Kubala et al. 2001, 2002) and many others. 
IL-10 is referred to as a cytokine with anti-
inflammatory activity. It is produced by the CD4+/TH1 
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and CD4+/TH2 subsets of lymphocytes, B lymphocytes 
and macrophages/monocytes (Wakkach et al. 2000).  
IL-10 inhibits the activation and proliferation of 
T lymphocytes, downregulates the production of pro-
inflammatory cytokines and the expression of various cell 
surface antigens associated with the induction of 
inflammation (Wakkach et al. 2000). IL-10 exerts direct 
anti-inflammatory and immunosuppressive effects on 
various cell types (Raychaudhuri et al. 2000, Roilides et 
al. 2000). Previously, IL-10 was reported as a potent 
inhibitor of phagocyte H2O2 production (Bogdan et al. 
1991), nitric oxide synthesis (Gazzinelli et al. 1992) and 
microbicidal activity (Silva et al. 1992). These activities 
of IL-10, together with its capacity to reduce the 
production of pro-inflammatory cytokines and 
chemokines, indicate that IL-10 is a potent 
immunosuppressant in vitro (de Vries 1995, Yano et al. 
1995). Therefore, IL-10 appeared to be a promising agent 
for the therapeutic treatment of acute inflammations 
(Huber et al. 2000). However, its direct effect on 
phagocytes is still a matter of discussion. Conversely, 
cytokines such as IL-6, IL-8 and TNF-α are potent pro-
inflammatory mediators with a wide range of biological 
activities (Pirenne et al. 1994). They have been shown to 
activate blood phagocyte chemotaxis, the expression of 
various adhesion molecules with consequent adhesion to 
endothelial cells, infiltration into tissues and the release 
of ROS, proteolytic enzymes and other bioactive 
substances (Pirenne et al. 1994). 
The present study was designed to determine the 
effect of IL-10 on blood phagocyte activity: ROS 
production and the expression of surface antigens 
involved in phagocyte adhesion and phagocytosis, 
namely the complement receptor 3 (CD11b), Lewis-X 
(CD15), L-selectin (CD62L) and platelet-endothelial cell 
adhesion molecule (CD31). The combined effects of  
IL-10 and pro-inflammatory cytokines (IL-6, IL-8,  
TNF-α) were also tested at various times of incubation. 
 
Material and Methods 
 
Reagents 
Recombinant human (rh) IL-10, IL-6, IL-8, and 
TNF-α were obtained from R&D Systems (USA). 
Phorbol myristate acetate (PMA), zymosan A from 
saccharomyces cerevisiae and luminol were obtained 
from Sigma-Aldrich (USA). Lysing solution Cal-Lyse, 
fluorescein isothiocyanate (FITC)-labeled anti-human 
CD62L murine monoclonal antibody, FITC-labeled anti-
human CD15 murine monoclonal antibody, 
phycoerythrin (PE)-labeled anti-human CD11b murine 
monoclonal antibody, PE-labeled anti-human CD31 
murine monoclonal antibody and appropriate control 
isotype murine antibodies were purchased from Caltag 
Laboratories (USA). Phycoerythrincyanin 5.1 (PC5)-
labeled anti-human CD14 murine monoclonal antibody 
was purchased from Immunotech (USA). 
Dihydrorhodamine-123 (DHR-123) was purchased from 
Molecular Probes (USA). All other chemicals were 
purchased in the highest grades from local distributors. 
 
Blood sampling and cytokine reconstitution 
Heparinized blood samples (50 IU/ml) were 
obtained from five healthy volunteers having given 
informed consent. Blood was diluted ten times with 
Hanks balanced salt solution (HBSS). The recombinant 
human cytokines were reconstituted to a concentration of 
10 µg/ml in HBSS containing 5 % bovine serum albumin. 
These cytokine solutions were further diluted with HBSS 
to obtain stock solutions. The final concentration of 
bovine serum albumin did not exceed 0.001 %. 
 
Experimental protocol 
Four experimental protocols were used in this 
study. Protocol A – diluted blood samples were incubated 
with various concentrations (400, 800, 1200 and 1600 
pg/ml) of IL-10, IL-6, IL-8 or TNF-α at 37 oC for 15 min 
or 2 h prior to the measurement of ROS production by 
luminol-enhanced chemiluminescence (CL). Protocol B – 
blood samples were incubated with 1200 pg/ml of IL-10, 
IL-6, IL-8 or TNF-α at 37 oC for 2 h prior to the 
determination of selected surface antigens and 
intracellular ROS production using a flow cytometer. 
Protocols C and D were used to test the effects of IL-10 
on the pro-inflammatory cytokine induced changes in 
both total and intracellular ROS production as well as 
surface antigen expression. Protocol C – blood samples 
were pre-incubated with IL-10 (1200 pg/ml) for 1 h prior 
to 15 min or 2 h of incubation with pro-inflammatory 
cytokines (1200 pg/ml). Protocol D – blood samples were 
simultaneously incubated with IL-10 (1200 pg/ml) and 
pro-inflammatory cytokines (1200 pg/ml). HBSS was 
used instead of cytokines as a control. The viability of 
leukocytes was determined by trypan blue exclusion after 
a hypotonic lysis of a part of each sample at the end of 
the incubations. The leukocyte viability of any sample did 
not decrease below 95 %. 
 
2004  IL-10 Does Not Affect the Activity of Human Blood Phagocytes    201  
   
Measurement of blood phagocyte oxidative burst 
Two different methods for ROS detection were 
used to obtain comprehensive information about the 
oxidative burst of phagocytes. 
 
Chemiluminescence determination of ROS 
Chemiluminescence of the diluted blood was 
measured using a microplate luminometer LM-01T 
(Immunotech, Czech Republic). The principle of the 
method is based on luminol interaction with phagocyte-
derived free radicals, which results in large measurable 
amounts of light. Briefly, the reaction mixture consisted 
of 100 µl of diluted blood, 1 mM luminol (stock solution 
of 10 mM luminol in 0.2 M borate buffer) and one of the 
activators (PMA – 0.4 µM or OZP – 0.25 mg/ml). The 
total reaction volume of 130 µl was adjusted with HBSS. 
The assays were run in duplicates. Spontaneous CL 
measurements in samples containing 100 µl of diluted 
blood and all other substances, but none of the activators, 
were included in each assay. The CL emission was 
followed for 90 min at 37 oC. The integral value of the 
CL reaction, which represents the total ROS production 
by blood phagocytes was evaluated. 
 
Flow cytometric determination of ROS 
Diluted blood samples (100 µl) were incubated 
with 10 µM DHR-123 (stock solution 10 mM DHR in 
dimethyl sulphoxide) and an anti-CD14 monoclonal 
antibody (2 µl). The tubes were shaken gently and 
incubated in the dark at 37 oC for 20 min. Then either 
PMA (0.4 µM) or OZP (0.25 mg/ml), or HBSS was 
added and the cell suspensions were incubated in the dark 
at 37 oC for further 20 min. At the end of the incubation 
period samples were fixed with Cal-lyse. The red blood 
cells were lysed by distilled water. The remaining cells 
were resuspended in PBS, placed on ice and analyzed 
within 2 h on the flow cytometer similarly to the analysis 
of surface antigens. 
 
Determination of the cell surface expression of adhesion 
molecules 
The measurements were performed according to 
the manufacturer’s protocol (Caltag Laboratories, USA) 
for unfixed whole blood. Briefly, 100 µl of diluted blood 
was incubated in plastic tubes (Falcon, USA) with anti-
CD11b, anti-CD15, anti-CD62L and anti-CD31 
monoclonal antibodies (two antibodies per vial, 5 µl of 
each). Blood (100 µl) was incubated with FITC- or PE-
conjugated murine immunoglobulins of the same isotype 
were used as the negative controls. Each tube also 
contained anti-CD14 monoclonal antibody (2 µl) for the 
discrimination of monocytes. Samples were incubated at 
room temperature for 15 min and then fixed with Cal-
lyse. The red blood cells were lysed with distilled water. 
The remaining cells were resuspended in PBS, placed on 
ice and analyzed within 2 h by a flow cytometer 
FACSCalibur (Becton Dickinson, USA). Blood 
granulocytes and monocytes were selected on the basis of 
their typical scattering characteristics and their different 
expression of CD14 antigen. The median fluorescence 
intensity (MFI) was determined and corrected for 
unspecific staining by subtracting the fluorescence of 
cells stained with the control antibody (isotype control). 
 
Statistical analysis 
The results were analyzed by Student t-test for 
independent or dependent samples and significances were 
verified by the non-parametric Mann-Whitney U-test or 
Wilcoxon test using Statistica for Windows 5.0 (Statsoft, 
USA). The differences of p<0.05 were regarded as 
statistically significant. All values are reported as the 




Influence of cytokines on spontaneous ROS production 
measured by chemiluminescence 
No significant differences in the spontaneous 
ROS production were found among control samples and 
samples incubated with IL-10, IL-6 or IL-8 at any of the 
concentrations used either after 15 min or 2 h of 
incubation (Fig. 1). TNF-α significantly increased the 
spontaneous ROS production when compared with the 
controls at all concentrations used after 15 min of 
incubation (Fig. 1A). The effect of TNF-α after 2 h of 
incubation was not significant (Fig. 1B). 
 
Influence of cytokines on activated ROS production 
measured by chemiluminescence 
After 15 min of incubation, PMA-activated ROS 
production was significantly increased by IL-6 at a 
concentration of 1600 pg/ml and by TNF-α at all tested 
concentrations when compared with control samples 
(Fig. 1A). However, IL-6 at concentrations of 800, 1200 
and 1600 pg/ml, IL-8 at a concentration of 1600 pg/ml 
and TNF-α at all tested concentrations significantly 
increased PMA-activated ROS production after 2 h of 
incubation (Fig. 1B). OZP-activated ROS production was 
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significantly increased by IL-6 at a concentration of 1600 
pg/ml, by IL-8 at concentrations of 1200 and 1600 pg/ml 
and by TNF-α at all tested concentrations when 
compared with the controls after 15 min of incubation 
(Fig. 1A). On the other hand, OZP-activated ROS 
production was significantly enhanced by all the tested 
concentrations of IL-6, IL-8 and TNF-α with the 
exception of IL-6 and IL-8 at concentrations of 400 pg/ml 
after 2 h of incubation. IL-10 at concentrations of 1200 
and 1600 pg/ml significantly increased OZP-activated 
ROS production after 2 h of incubation (Fig. 1B). 
 
 
Fig. 1. Effects of IL-10, IL-6, IL-8 and TNF-α at concentrations of 400, 800, 1200 and 1600 pg/ml on spontaneous and PMA- or OZP-
activated ROS production by blood phagocytes after 15 min (A) and 2 h (B) of incubation. Results are expressed as percentages of 
controls. The asterisk indicates significant (p<0.05) difference vs. control incubated in the absence of cytokine (n=5). 
 
 
Influence of cytokines on ROS production measured by 
DHR-123 
IL-10 and IL-8 did not significantly affect either 
spontaneous or activated intracellular ROS production by 
neutrophils or monocytes. Incubation of blood samples 
with IL-6 significantly increased spontaneous and 
OZP-activated ROS production by neutrophils and PMA-
activated ROS production by monocytes (Table 1). 
TNF-α increased significantly spontaneous and PMA- or 
OZP-activated ROS production by both neutrophils and 
monocytes when compared with the controls. 
  
Influence of cytokines on the expression of adhesion 
molecules 
IL-10 did not significantly affect the expression 
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CD62L and CD31) (Fig. 2). IL-6 and TNF-α induced 
significant increases in CD11b and CD15 expression and 
a decrease in CD62L expression on both neutrophils and 
monocytes when compared with control samples. IL-8 
significantly increased the expression of CD11b on 
neutrophils and CD15 on both neutrophils and 
monocytes. IL-8 did not affect the expression of CD62L. 
The expression of CD31 was not significantly affected by 
any of the tested cytokines. 
 
 
Table 1. The influence of IL-10 (1200 pg/ml) on spontaneous and PMA- or OZP-activated ROS production by neutrophils and 
monocytes measured by DHR-123. Blood samples were simultaneously incubated with IL-10 and with IL-6, IL-8 or TNF-α (1200 pg/ml) 
for 2 h or preincubated with IL-10 for 1 h before a 2 h incubation with IL-6, IL-8 or TNF-α (1200 pg/ml).  
 
 NEUTROPHILS MONOCYTES 
 
 Individual  Simultaneous Pre- Individual  Simultaneous Pre- 
 cytokines  incubation incubation cytokines  incubation incubation  
  with IL-10 with IL-10  with IL-10 with IL-10 
 
Spontaneous IL-10 101±6 – – 96±9 – – 
 IL-6 125±11* 114±14 116±4* 119±8* 117±8 118±3* 
 IL-8 101±8 108±11 98±3 94±11 103±4 104±7 
 TNF-α 135±18* 137±14* 150±27* 145±19* 155±25* 151±18* 
 –  – – 99±11 – – 97±5 
PMA-activated IL-10 109±13 – – 103±5 – – 
 IL-6 112±4 126±18* 110±7 127±11* 128±7* 117±5* 
 IL-8 102±6 114±25 111±7  96±7 104±6 104±4 
 TNF-α 122±18* 133±21* 129±14* 119±6* 121±9* 128±18* 
 –  – – 110±12 – – 89±17 
OZP-activated IL-10 114±26 –  – 103±5 –  – 
 IL-6 124±16* 118±6* 129±10* 113±5* 107±10 109±15 
 IL-8 114±16 115±12 112±12  103±7  110±13 108±4  
 TNF-α 126±14 * 120±15* 122±11* 119±6* 125±14* 126±14* 
 – – – 96±11 –  – 91±8 
 
 
Results are expressed as percentages of controls incubated without any cytokine. The asterisk indicates significant (p<0.05) difference 
between controls and samples incubated simultaneously with IL-10 or preincubated with IL-10 for 1 h (n=5). 
 
 
Influence of simultaneous incubation of IL-10 with 
individual pro-inflammatory cytokines 
Simultaneous incubation of blood with IL-10 
along with IL-6 or TNF-α did not significantly influence 
either spontaneous or PMA- or OZP-activated ROS 
production measured by CL when compared with 
analogous samples incubated without IL-10 at both 
15 min and 2 h time intervals (Table 2). A simultaneous 
incubation of blood with IL-10 and IL-8 did not influence 
ROS production when compared with analogous samples 
incubated without IL-10 with the exception of 
spontaneous (significant increase) and OZP-activated 
(significant decrease) ROS production after 2 h of 
incubation (Table 2). 
Simultaneous incubation of blood samples with 
IL-10 (1200 pg/ml) and any of the pro-inflammatory 
cytokines did not significantly affect either spontaneous 
or PMA- or OZP-activated ROS production by 
neutrophils or monocytes measured by DHR-123 when 
compared with analogous samples incubated without  
IL-10 (Table 1). 
Simultaneous incubation of blood with IL-10 
(1200 pg/ml) and any of the pro-inflammatory cytokines 
did not significantly affect the expression of any 
evaluated surface molecules on either neutrophils or 
monocytes when compared with analogous samples 
without IL-10 (data not shown). 
 
Influence of preincubation with IL-10 on the priming 
effect of pro-inflammatory cytokines 
Preincubation of blood with IL-10 for 1 h before 
15 min or 2 h incubation with individual pro-
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inflammatory cytokines did not have any influence on 
either spontaneous or activated ROS production 
measured by CL when compared with analogous  
samples without IL-10 pre-incubation (Table 2). 
Similarly, preincubation of blood with IL-10 for 1 h 
before incubation with individual pro-inflammatory 
cytokines did not significantly affect either  
spontaneous or PMA- or OZP-activated intracellular ROS 
production by neutrophils or monocytes as measured by 
DHR-123, when compared with analogous samples 
without IL-10 preincubation (Table 1). The expression of 
any evaluated surface molecules either on neutrophils or 
monocytes was not significantly affected when compared 
with analogous samples without IL-10 preincubation 
(data not shown). 
 
 
Table 2. The influence of IL-10 (1200 pg/ml) on spontaneous and PMA- or OZP-activated ROS production by blood phagocytes 
measured by luminol-enhanced chemiluminescence. Blood samples were simultaneously incubated with IL-10 and with IL-6, IL-8 or 
TNF-α (1200 pg/ml) for 15 min or 2 h or preincubated with IL-10 for 1 h before 15 min or 2 h of incubation with IL-6, IL-8 or TNF-α 
(1200 pg/ml).  
 
 Without Simultaneous Pre- Without Simultaneous Pre- 
  incubation incubation  incubation incubation 
 IL-10 with IL-10 with IL-10 IL-10 with IL-10 with IL-10 
 
  15 min incubation 2 h incubation 
 
Spontaneous IL-6 106±3 99±6 105±3 101±3 91±11 111±17 
 IL-8 107±4 98±2 99±1 93±6 111±6† 86±15 
 TNF-α 141±1* 137±14* 166±25* 100±5 95±8 112±18 
 – – – 101±1 – – 94± 8 
PMA-activated IL-6 93±3 91±1* 103±4 121±10* 129±13* 117±15 
 IL-8 95±7 94±8 118±3* 96±5 99±4 107±15 
 TNF-α 168±14* 148±13* 170±6* 170±27* 174±31* 168±41 * 
 – – – 102±7 – – 96±9 
OZP-activated IL-6 105±16 100±5 110±6 146±10* 150±21* 139±18 * 
 IL-8 116±5* 102±4 118±4* 123±9* 92±6† 121±16 * 
 TNF-α 197±28* 192±22* 177±19* 203±39* 204±57* 206±54* 
 – – – 116±5* – – 90±9  
 
Results are expressed as percentages of controls incubated without any cytokine. The cross indicates significant (p<0.05) difference 
between samples without IL-10 and analogous samples simultaneously incubated or preincubated with IL-10 (n=5). For other symbols 





IL-10 is classified as an anti-inflammatory 
cytokine (Vicioso et al. 1998). However, its effect on 
phagocytes, which belong to the key components of the 
inflammatory response, is still a matter of discussion. In 
the present study, the influence of IL-10 on human blood 
phagocytes was tested by monitoring ROS production 
and the expression of several adhesion molecules on 
neutrophils and monocytes in the presence and in the 
absence of selected pro-inflammatory cytokines. In our 
experimental conditions, IL-10 did not have any 
inhibitory effect on ROS production by blood 
phagocytes. On the contrary, IL-10 at concentrations of 
1200 and 1600 pg/ml significantly enhanced the activated 
ROS production after 2 h of incubation which agrees with 
our previous observations (unpublished data). Bussolati 
et al. (1997) found that IL-10 directly stimulated an early 
production of superoxide by monocytes and to a slight 
extent by PMNL, but inhibited the subsequent 
phagocytosis and the ability of these cells to respond to 
fMLP. Roilides et al. (2000) found that IL-10 (2-100 
ng/ml) did not have any significant effect on the activated 
oxidative burst of PMNL after 1 h of incubation. Our 
results also show that the expression of neutrophil and 
monocyte surface antigens CD11b, CD15, CD31 and 
CD62L (Kubala et al. 2002ab) is not modified by IL-10. 
Similarly Vicioso et al. (1998) did not observe any effect 
of IL-10 (10 ng/ml) on CD11b/CD18 expression on 
PMNL and monocytes after 30 min of incubation. In 
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contrast, some authors have shown that  
IL-10 downregulated the expression of CD11b (Laichalk 
et al. 1996), chemotaxis (Vicioso et al. 1998) and the 
ability of phagocytosis (Laichalk et al. 1996). 
 
 
Fig. 2. Effects of IL-10, IL-6, IL-8 and TNF-α at a concentration of 1200 pg/ml on the expression of surface molecules (CD11b, CD15, 
CD62L and CD31) on neutrophils (hatched bars) and monocytes (full bars) after 2 h of incubation. Results are expressed as 
percentages of controls. The asterisk indicates significant (p<0.05) difference vs. control incubated in the absence of cytokine (n=5). 
 
 
Furthermore, the effects of IL-10 in the presence 
of individual pro-inflammatory cytokines were analyzed 
in our study. Each of the tested pro-inflammatory 
cytokines alone induced a strong increase in phagocyte 
ROS production. The influence of TNF-α was the most 
effective at all the concentrations used as early as after 
15 min of incubation. Other authors also found that IL-6, 
IL-8 and TNF-α enhanced the cytotoxicity and primed 
the oxidative burst of PMNL (Borish et al. 1989, Elbim et 
al. 1994, Elbim and Gougerot-Pocidalo 1996, Niwa et al. 
1996, Vondráček 1997). Khwaja et al. (1992) observed a 
fast response of blood phagocytes to TNF-α stimulation 
after 10-20 min. Finally, in agreement with the literature 
(Baggiolini et al. 1994, Asman et al. 1996), IL-6, IL-8 
and TNF-α increased the expression of CD11b and CD15 
and decreased the expression of CD62L on both 
neutrophils and monocytes. Surprisingly, IL-10 did not 
have any influence on the priming effect of IL-6, IL-8, 
TNF-α on phagocyte ROS production and the expression 
of adhesion molecules during simultaneous incubation. 
Our results are in accord with Reglier-Pouplet et al. 
(1998) who showed that IL-10 did not have a direct effect 
on production of H2O2 and did not modulate priming 
effect of TNF-α on the response to fMLP. The only 
exception was that IL-10 abolished the stimulating effect 
of IL-8 on OZP-activated ROS production. It was also 
observed that preincubation with IL-10 did not affect the 
changes induced by IL-6, IL-8 or TNF-α. Ωε also 
confirmed that IL-10 did not have an inhibitory effect on 
phagocyte activity in vitro at the tested concentrations. 
The influence of IL-10 on the activation of blood 
phagocytes in vitro could be affected by several factors. 
The effects of cytokines are dose-dependent so that the 
selection of tested concentrations is very important for in 
vitro experiments (Laichalk et al. 1996, Capsoni et al. 
1997). The concentrations of cytokines used in our study 
were selected on the basis of previous studies (Kubala et 
al. 2001, 2002ab) and other clinical studies on patients in 
various pathophysiological situations when the highest 
plasma level of any tested cytokine did not exceed 2 
ng/ml (Lang et al. 1996). When high concentrations (10-
100 ng/ml) of IL-10 were used for in vitro experiments, 
IL-10 downregulated the generation of ROS by blood 
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slightly augmented phagocytosis by monocytes and 
decreased phagocytosis by neutrophils (Buchwald et al. 
1999). ICAM-1 expression on monocytes was markedly 
enhanced by IL-10 in the concentration range of 1 to 100 
ng/ml, while the expression on neutrophils was not 
affected (Buchwald et al. 1999). Surface expression of 
IL-10 receptor on blood phagocytes is another important 
factor affecting the influence of IL-10 on phagocyte 
activity. It was reported that expression of IL-10 
receptors on the surface of resting blood granulocytes 
was low and was not sufficient to induce a response of 
these cells to IL-10 (Elbim et al. 2001). These authors 
observed that a preincubation of cells with TNF-α for 10-
40 min induced an increase of the expression of IL-10 
receptor and consequently induced the responsiveness of 
cells to IL-10 which was expressed by a lower production 
of superoxide. 
Another explanation for the absence of anti-
inflammatory activity of IL-10 could be a short 
incubation of diluted blood with cytokines in our study. 
Bogdan et al. (1991) found that IL-10 reduced the 
generation of ROS when macrophages were preincubated 
with IL-10 for 48 h and then stimulated by PMA. 
Similarly, the incubation of monocytes or PMNL with 
IL-10 for 24 h before stimulating these cells with fMLP 
decreased superoxide production (Bussolati et al. 1997). 
Incubation of neutrophils with IL-10 for 18 h down-
regulated their capacity to produce a superoxide anion, 
but conversely, shorter incubation times with IL-10, from 
30 min to 5 h, were ineffective (Capsoni et al. 1997). It 
seems that the anti-inflammatory properties of IL-10 
could be observed mainly after long incubation times of 
blood phagocytes with IL-10. However, a massive 
increase of IL-10 occurs in vivo at the same time as a 
massive increase of pro-inflammatory cytokines which 
cause phagocyte activation at time intervals up to several 
hours. Therefore, if an increase of IL-10 is protective 
against damage caused by activated phagocytes, as has 
been suggested by several authors (Kubala et al. 2001, 
Wan et al. 1997), it has to affect the phagocytes’ activity 
at these time intervals. Therefore, the incubation times in 
our experiments did not exceed three hours. 
Most studies have been performed on PMNL or 
monocytes isolated from blood by various procedures, 
which may modulate ROS production (Číž and Lojek 
1997), surface receptor expression (Zahler et al. 1997), 
and thus alter the cell response. Therefore, in this study 
we measured the activation of blood phagocytes in 
diluted blood in order to avoid PMNL and monocyte 
activation and to simulate the in vivo situation more 
closely. 
In conclusion, pro-inflammatory effects of IL-6, 
IL-8 and TNF-α expressed as an increased ROS 
production and the enhanced expression of adhesion 
molecules by neutrophils and monocytes were observed 
in vitro. These effects were dependent on cytokine 
concentrations and the time of incubation of blood with 
cytokines. On contrary, our results show that IL-10 does 
not have any direct anti-inflammatory activity towards 
blood phagocytes. The properties of IL-10 described in 
our study should be taken into consideration in 
therapeutic strategies where some anti-inflammatory 
benefit of IL-10 is expected. 
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